Poliovirus Receptor as a Potential Target in Gastric Signet-Ring Cell Carcinoma for Antibody-Drug Conjugate Development

This preliminary study supports the further development of PVR-DXd as a candidate therapy for advanced GSRCC.

Authors

Institutions

Publication Details

Journal
Cancers
Published
2026-01-15
DOI
https://doi.org/10.3390/cancers18020270
Primary Topic
HER2/EGFR in Cancer Research
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Poliovirus Receptor as a Potential Target in Gastric Signet-Ring Cell Carcinoma for Antibody-Drug Conjugate Development

Shengjie Zhang, Xuefei Tian, Hanfei Xie, Xiangdong Cheng et al.
Cancers
HER2/EGFR in Cancer Research
article

Poliovirus Receptor as a Potential Target in Gastric Signet-Ring Cell Carcinoma for Antibody-Drug Conjugate Development

Shengjie Zhang, Xuefei Tian, Hanfei Xie, Xiangdong Cheng, Li Yuan, Yinxia Zhao, Yujie Dai, Peng Guo, Can Hu
article en

Abstract

This preliminary study supports the further development of PVR-DXd as a candidate therapy for advanced GSRCC.

CancersVol. 18(2)
Tianjin University (CN), Chinese Academy of Sciences (CN), University of Macau (MO), Fudan University (CN), Zhejiang Cancer Hospital (CN), Hangzhou Academy of Agricultural Sciences (CN), Institute for Advanced Study (DE), Hangzhou Cancer Hospital (CN)
Chinese Academy of Sciences
No poverty, Good health and well-being
Openalex Percentile: Top 87%
HER2/EGFR in Cancer Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Poliovirus Receptor as a Potential Target in Gastric Signet-Ring Cell Carcinoma for Antibody-Drug Conjugate Development — Shengjie Zhang, Xuefei Tian, et al. · Cancers (2026) | TGRS Research Map | TGRS